Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.73 - $8.65 $365 - $4,325
-500 Reduced 3.26%
14,840 $12,000
Q2 2022

Aug 10, 2022

SELL
$0.75 - $1.33 $7,500 - $13,300
-10,000 Reduced 39.46%
15,340 $12,000
Q4 2021

Feb 09, 2022

SELL
$1.63 - $2.83 $2,282 - $3,962
-1,400 Reduced 5.24%
25,340 $42,000
Q3 2021

Nov 09, 2021

SELL
$2.45 - $3.45 $343 - $483
-140 Reduced 0.52%
26,740 $70,000
Q2 2021

Jul 29, 2021

SELL
$3.3 - $5.02 $18,876 - $28,714
-5,720 Reduced 17.55%
26,880 $92,000
Q1 2021

Apr 29, 2021

BUY
$4.29 - $9.94 $8,580 - $19,880
2,000 Added 6.54%
32,600 $164,000
Q4 2020

Jan 22, 2021

BUY
$2.41 - $5.63 $73,746 - $172,278
30,600 New
30,600 $144,000

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $61.4M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.